Section Arrow
CADL.NASDAQ
- Candel Therapeutics
Quotes are at least 15-min delayed:2026/08/29 19:59 EDT
Regular Hours
Last
 13.07
-0.68 (-4.95%)
Day High 
13.7999 
Prev. Close
13.75 
1-M High
14 
Volume 
1.24M 
Bid
12.93
Ask
13
Day Low
12.88 
Open
13.635 
1-M Low
9.1612 
Market Cap 
1.05B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 12.84 
20-SMA 11.71 
50-SMA 10.48 
52-W High 14 
52-W Low 4.35 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.47/-0.59
Enterprise Value
1.10B
Balance Sheet
Book Value Per Share
1.65
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QNRXQuoin Pharmaceuticals Ltd6.12+0.965+18.72%-- 
MRNAModerna137.99-4.78-3.35%-- 
CELUCelularity1.58-0.52-24.76%-- 
VBIOValion Bio Inc.0.1209-0.0017-1.39%-- 
RXRXRecursion Pharmaceuticals3.34-0.1-2.91%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.